The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer
Open accessPublished version of a preprint
Abstract
Recent studies have identified a unique cancer-associated fibroblast (CAF) population termed antigen-presenting CAFs (apCAFs), characterized by the expression of major histocompatibility complex class II molecules, suggesting a function in regulating tumor immunity. Here, by integrating multiple single-cell RNA-sequencing studies and performing robust lineage-tracing assays, we find that apCAFs are derived from mesothelial cells. During pancreatic cancer progression, mesothelial cells form apCAFs by downregulating mesothelial features and gaining fibroblastic features, a process induced by interleukin-1 and transforming growth factor β. apCAFs directly ligate and induce naive CD4 + T cells into regulatory T cells (Tregs) in an antigen-specific manner. Moreover, treatment with an antibody targeting the mesothelial cell marker mesothelin can effectively inhibit mesothelial cell to apCAF transition and Treg formation induced by apCAFs. Taken together, our study elucidates how mesothelial cells may contribute to immune evasion in pancreatic cancer and provides insight on strategies to enhance cancer immune therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“lineage tracing analysis of perivascular fibroblasts, expressing the transcription factor Gli1, showed this population expands to form nearly half of pre-CAFs in PanINs and CAFs in cancer”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [144]
In the citing paper
“parenchymal fibroblasts, expressing Hoxb6 do not expand during carcinogenesis144”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [144]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrated analysis of multimodal single-cell data
Hao, Y., Hao, S., Andersen-Nissen, E., Mauck, W. M., Zheng, S., Butler, A., Lee, M. J., Wilk, A. J., Darby, C., Zagar, M., et al. (2020) · doi:10.1101/2020.10.12.335331 · Cited by 15,508
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Zhou, Y., Zhou, B., Pache, L., Chang, M., Khodabakhshi, A. H., Tanaseichuk, O., Benner, C., & Chanda, S. K. (2019) · Nature Communications · doi:10.1038/s41467-019-09234-6 · Cited by 14,611
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Reversed graph embedding resolves complex single-cell trajectories
Qiu, X., Mao, Q., Tang, Y., Wang, L., Chawla, R., Pliner, H. A., & Trapnell, C. (2017) · Nature Methods · doi:10.1038/nmeth.4402 · Cited by 5,070
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590
Cited by
Sorted by citations
Items 301–400 of 540
Srinivasan, D., Gout, J., Kleger, A., & Roger, É. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115697 · Cited by 7
Decoding the role of mesothelin in tumor dynamics and targeted treatment innovations
Silvestri, R., Colucci, E., Piccardi, M., Landi, S., & Gemignani, F. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00379-z · Cited by 7
IL-1β-mediated suppression of CIITA attenuates IFN-γ-induced MHC-II expression on Fibroblasts
Chen, L., Jiang, H., Tan, B., Geng, R., Chen, J., Wu, S., Zhang, F., Lang, Y., Ma, H., Zheng, X. W., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02575-4 · Cited by 7
Lv, Y., Duan, T., Song, J., Liu, S., Zhou, Z., Ba, Y., Weng, S., Zuo, A., Xu, H., Luo, P., et al. (2026) · 癌症:英文版 · doi:10.34133/cancomm.0002 · Cited by 7
Self-citationLiu, R., Su, L., Gao, S., Liu, W., & Wang, H. (2026) · Advanced Science · doi:10.1002/advs.202510043 · Cited by 9
Research highlights in cancer immunotherapy from basic discovery to clinical trial
Wang, C. (2022) · Holistic Integrative Oncology · doi:10.1007/s44178-022-00012-x · Cited by 7
Fibroblast subtypes in pancreatic cancer and pancreatitis: from mechanisms to therapeutic strategies
Huang, H., Lu, W., Zhang, X., Pan, J., Cao, F., & Li, W. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00874-x · Cited by 7
Self-citationTop advances of the year: Pancreatic cancer
Warren, E. A. K., Lesinski, G. B., & Maithel, S. K. (2023) · Cancer · doi:10.1002/cncr.35031 · Cited by 7
Cadamuro, M., Nuozzi, G., Simioni, P., & Fabris, L. (2023) · Hepatoma Research · doi:10.20517/2394-5079.2023.94 · Cited by 8
Differential induction of T-cell tolerance by tumour fibroblast subsets
Chua, Z. M. X., Tajebe, F., Abuwarwar, M. H., & Fletcher, A. L. (2024) · Current Opinion in Immunology · doi:10.1016/j.coi.2023.102410 · Cited by 7
Ming, H., Li, B., Tian, H., Qin, S., Zhang, T., Liu, S., Gao, Y., Yang, C., Chen, L., Ni, J., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.157288 · Cited by 7
Yang, Y., Xing, S., Luo, X., Guan, L., Lü, Y., Wang, Y.-T., & Feng, W. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1158852 · Cited by 7
Li, B., Shi, M., Wang, Y., Li, P., Yin, X., Zhang, G., Kang, X., Wang, H., Gao, S., Zheng, K., et al. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102282 · Cited by 6
Wang, R., Yan, Q., Guo, X., Song, F., Xiong, Z., Cai, S., Bian, X., Wong, M. H., Cao, Q., Cheng, L., et al. (2025) · Genome Medicine · doi:10.1186/s13073-025-01441-9 · Cited by 7
Bao, Y., Chen, J., Han, X., He, Y., Yang, T., Shi, X., Chen, J., Gu, L., Wang, S., Xie, L., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.039195 · Cited by 6
Tian, J., Ye, L., Wang, Z., Zhong, Y., Yao, Y., & Sun, C. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115193 · Cited by 7
Self-citationQiao, Y., Yin, H., Zhang, Y., Zhang, J., & Dong, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1585858 · Cited by 8
Self-citationXia, W., Wang, H., Dong, Y., Yang, Z., Zhou, Y., Xia, Z., Li, Q., Ren, L., Zheng, Y., Yan, J., et al. (2026) · Advanced Science · doi:10.1002/advs.202512627 · Cited by 6
Hirano, Y., Suzuki, H., Nakayama, J., Yamamoto, T., Hirata, E., Araya, J., Fujita, Y., & Yamamoto, Y. (2026) · npj Precision Oncology · doi:10.1038/s41698-026-01279-3 · Cited by 7
Liu, Y., Han, X.-L., Han, Y., Bi, J., Wu, Y., Xiang, D., Zhang, Y., Bi, W., Xu, M., & Li, J. (2024) · Gene · doi:10.1016/j.gene.2024.148286 · Cited by 6
Self-citationFei, Y., Wu, Y., Chen, L., Yu, H., & Pan, L. (2024) · Discover Oncology · doi:10.1007/s12672-024-00901-9 · Cited by 6
Epigenetic regulation of the tumor microenvironment: A leading force driving pancreatic cancer
Vera, R. E., Lamberti, M. J., González, A. L., & Fernández-Zapico, M. E. (2024) · Pancreatology · doi:10.1016/j.pan.2024.07.005 · Cited by 6
Establishment of a Prognostic Model for Pancreatic Cancer Based on Hypoxia-Related Genes
Wu, Y., Zhou, J., Kou, Q., Sun, L., Ma, Y., Yang, T., & Hu, X. (2024) · Technology in Cancer Research & Treatment · doi:10.1177/15330338241288687 · Cited by 6
Thomas, M. E., Jie, E., Kim, A. M., Mayberry, T. G., Cowan, B. C., Luechtefeld, H. D., Wakefield, M. R., & Fang, Y. (2024) · Medical Oncology · doi:10.1007/s12032-024-02564-6 · Cited by 9
A dynamic molecular landscape in colorectal cancer progression at single-cell resolution
Sheng, J., Li, N., Li, S., Ye, Y., Liao, Y., Zhang, Y., Chen, H., Tu, M., Zhong, G., Xiong, C., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06785-9 · Cited by 8
Self-citationIjichi, H. (2022) · Cancers · doi:10.3390/cancers14194880 · Cited by 6
Regulation of Mesothelial Cell Fate during Development and Human Diseases
Taniguchi, T., Tomita, H., Kanayama, T., Mogi, K., Koya, Y., Yamakita, Y., Yoshihara, M., Kajiyama, H., & Hara, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911960 · Cited by 6
Advancement of single-cell sequencing for clinical diagnosis and treatment of pancreatic cancer
Zhang, K., Chen, Y., Zhu, J., Ge, X., Wu, J., Xu, P., & Yao, J. J. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1213136 · Cited by 6
Selective targeting or reprogramming of intra-tumoral Tregs
Mortezaee, K. (2024) · Medical Oncology · doi:10.1007/s12032-024-02300-0 · Cited by 6
New trend in molecular diagnostics: Insights from the tumor microenvironment
Fan, B., Zhang, J., Li, C., & Zhang, X. (2025) · Interdisciplinary medicine · doi:10.1002/inmd.70048 · Cited by 9
Rapid CAR screening and circRNA-driven CAR-NK cells for persistent shed-resistant immunotherapy
Chung, J.-Y., Hong, J., Yee, S., Lim, H. W., Lee, D., Yoon, S.-W., Lee, S.-H., Jung, Y.-J., Shin, S. H., Kim, S. C., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02623-6 · Cited by 5
Gao, H., Nishikubo, H., Ma, D., Pan, J., Sano, T., Imanishi, D., Sakuma, T., Fan, C., & Yashiro, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199695 · Cited by 5
Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer
Wang, X., Shinjo, K., Kumegawa, K., Maruyama, R., Mii, S., Shiraki, Y., Nishimura, T., Murofushi, Y., Suzuki, M., Kabasawa, T., et al. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03299-5 · Cited by 7
Qi, L., Dang, G., Ling, X., Miao, Y., Bo, Y., Zhai, Y., Chen, X., Zhai, Q., Zheng, L., Zhang, Y., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-2871 · Cited by 9
Self-citationCytokines and cancer-associated fibroblasts
Hu, Y., Liang, J.-J., Duan, L., Zhu, J., Shan, G., Cheng, T., Wu, Y., Tan, L., & Zhan, C. (2026) · Journal of Hematology & Oncology · doi:10.1186/s13045-026-01801-x · Cited by 6
Cancer-associated fibroblast subtypes differentially modulate natural killer cells in cancer
Rodrigues, L. N., Munir, H., Arrazola, I. T., Gaida, M. M., Eckert, C., Jérôme Boulanger, A., Ferreira, A. C. F., McKenzie, A. N. J., & Shields, J. D. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117527 · Cited by 5
Zhang, G., Shu, Z., Yu, J. Q., Li, J., Yi, P., Wu, B., Deng, D., Yan, S., Li, Y., Ren, D., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1341209 · Cited by 5
Li, P., Zhang, X., Yan, H., Xia, X., Deng, Y., Miao, Q., Luo, Y., Liu, G., Luo, H., Zhang, Y., et al. (2024) · Translational Lung Cancer Research · doi:10.21037/tlcr-24-118 · Cited by 5
Self-citationWang, S., Van, K. V., Zheng, M., Chen, W., & Ma, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140418 · Cited by 5
Zheng, Y., Shao, W., Ge, T., Ge, S., Jia, R., Yang, L., & Zhuang, A. (2025) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.70005 · Cited by 5
Cancer-associated fibroblasts: multidimensional players in liver cancer
Pan, Y., Qiu, Y., Zhou, X., Mao, W., & Xu, X. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1454546 · Cited by 5
Lai, X., Fu, G., Du, H., Xie, Z., Lin, S., Li, Q., & Lin, K. (2023) · Medicine · doi:10.1097/md.0000000000035005 · Cited by 5
Macropinocytosis controls metabolic stress-driven CAF subtype identity in pancreatic cancerPreprint
Zhang, Y., Li, L., Maganti, S., Hope, J. L., Galapate, C. M., Carrette, F., Duong‐Polk, K., Bagchi, A., Scott, D. A., Lowy, A. M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.29.625709 · Cited by 5
Self-citationMaru, S. Y., Wetzel, M., Mitchell, J. T., Groß, N., Andaloori, L., Howe, K., Kartalia, E., Mo, G., Leatherman, J. M., Ho, W. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.27.645833 · Cited by 4
Bernard, V., Ku, L.-T., Wang, T., Acevedo-Diaz, A., Rajapakshe, K., Jacobson, G., Tovar, D., Min, J., Pei, G., Tat, C. L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.20.660757 · Cited by 5
Self-citationLiu, M., Li, T.-Z., & Xu, C. (2025) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2025.130796 · Cited by 5
Peng, S., Jia, K., Peng, M., Chen, Y., Lin, A., Luo, P., Wang, J., Wang, Y., & Bai, Y. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002526 · Cited by 4
The multifaced role of the macrophage migration inhibitory factor family in organ fibrosis
Herkens, L., Droste, P., & Boor, P. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00198.2025 · Cited by 5
Boeker, V., Wilke, L., Mansourkiaei, A., Le, V. M. H., Church, K. A., Czigány, Z., Kong, B., Kugeratski, F. G., Kleeff, J. H., Weitz, J., et al. (2025) · BJC Reports · doi:10.1038/s44276-025-00150-5 · Cited by 4
Zhang, C., Song, Y., Cui, X., Wang, Y., Liu, J., & Shen, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-06051-4 · Cited by 4
Suo, D., Liang, L., Xia, Z., Zhang, Y., Zeng, T., Li, S., Guan, X., & Li, Y. (2025) · Cellular Oncology · doi:10.1007/s13402-025-01090-5 · Cited by 4
Self-citationZhang, J., Zhang, D., Liu, X., Xu, M., He, J., Ma, J., & Yang, Z. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104965 · Cited by 5
Lin, Y., Sun, X., Li, C., Yang, M., Wu, K., Liu, K., Li, A., Shuai, X., Cai, K., Wang, Z., et al. (2025) · Advanced Science · doi:10.1002/advs.202508433 · Cited by 4
Self-citationShen, Y., Sun, Y., Li, X., Wang, Y., Huang, T., Li, T., Zhu, Y.-Z., Hu, L., & Xu, C. S. (2026) · Cancer Drug Resistance · doi:10.20517/cdr.2025.189 · Cited by 5
Uno, K., Yoshihara, M., Yamakita, Y., Kitami, K., Iyoshi, S., Sugiyama, M., Koya, Y., Kanayama, T., Sahara, H., Nomura, S., et al. (2026) · Science Advances · doi:10.1126/sciadv.adu5944 · Cited by 4
The Significance of the Heterogeneity of Cancer-Associated Fibroblasts in Tumor Microenvironments
Imanishi, D., Nishikubo, H., Ma, D., Gao, H., Sano, T., Fan, C., Sakuma, T., Yamamoto, Y., & Yashiro, M. (2026) · Metabolites · doi:10.3390/metabo16020120 · Cited by 4
Shi, T., Guo, Y., Tang, X., Liu, Z., Guo, Q., Fang, T., Xu, S., & Zhuang, Z. (2026) · Neoplasia · doi:10.1016/j.neo.2026.101348 · Cited by 9
Cai, S., Zhao, M., Yang, G., Li, C., Hu, M., Yang, L., Xing, L., & Sun, X. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112434 · Cited by 4
Liu, J., Shi, Z., Li, Y., Ma, J., Yao, J., Yuan, Z., Wang, Y., Yang, C., Li, X., Xing, N., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105801 · Cited by 5
EV-mediated asymmetrical crosstalk between CAFs and cancer cells in the tumor microenvironment
Santi, A., Moccia, A., Caselli, A., & Cirri, P. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189380 · Cited by 4
Tumor Microenvironment: Recent Advances in Immunotherapies of Pancreatic Cancer
Thankachan, S. V., Jayaraman, V., Datta, L., Apthi, S., Zaman, B. F., Gurunathan, R., Suresh, A., Chandrakesan, P., Vinayagam, R., Kang, S. G., et al. (2025) · Medicina · doi:10.3390/medicina61101776 · Cited by 5
Meng, S., Hara, T., Sato, H., Tatekawa, S., Tsuji, Y., Saito, Y., Hamano, Y., Arao, Y., Gotoh, N., Ogawa, K., et al. (2024) · Oncology Letters · doi:10.3892/ol.2024.14247 · Cited by 4
Tumor cell-intrinsic epigenetic SETpoint of cancer-associated fibroblasts
Chen, X., & Huang, H. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.04.001 · Cited by 5
Self-citationWang, D., & Chen, Z. (2025) · Visualized Cancer Medicine · doi:10.1051/vcm/2025005 · Cited by 4
Liu, M., Yu, H., Chen, L., Yang, D., Liu, H., Ouyang, J., Zhang, J., Xu, Y. K., Luo, Y., Lin, Y., et al. (2023) · Neuroendocrinology · doi:10.1159/000535385 · Cited by 4
Cao, Z., Jing, Y., Cheng, C., Wang, F., Guan, M., Zhang, K., Jiao, J., Ruan, L., & Chen, Z. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2903119 · Cited by 4
Zhang, C., Chen, F., Li, J., He, Y., Sun, J., Zheng, Z., Liu, G., Wang, Y., Kang, W., & Ye, X. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03878-9 · Cited by 3
Bowman, C. L., Daniel, C. J., Carlson, E. J., Shah, V. M., Farrell, A. S., Kresse, K. M., Wang, X., Lindley, K. A., Kuhn, M. R., Hawthorne, K., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-3437 · Cited by 6
Korah, M. M., Reveron‐Thornton, R. F., Fallah, M., Xie, P. Y., Gonçalves, A. C., Guo, C., Agolia, J. P., Delitto, A. E., Flojo, R. A. B., Reddy, B., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116347 · Cited by 4
High mesothelin expression is associated with low cytotoxic T cell infiltration in pancreatic cancer
Liang, O., White, A. L., Fielder, T., Shin, J., Sagnella, S. M., Schmitz, U., & Yeo, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1651687 · Cited by 3
Gao, X., Sun, L., Li, T., Li, P., Liu, C., Li, Q., & Zhu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1647988 · Cited by 3
Vasudev, A., Moore, C. R., Calindi, A., Kang, S., Helm, B. R., Srinivasan, J., Shah, S., Baker, E., Zong, R., Singarapu, N., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116677 · Cited by 4
Fibroblast-like cells in mesothelioma can derive from tumor cells
García-Manteiga, J. M., Rrapaj, E., Caprioglio, F., Marchis, F. D., Lamarca, A., Colley, L. S., Carretta, A., Finocchiaro, D., Mercalli, F., Molinario, A., et al. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-025-01639-9 · Cited by 3
Wang, D., Chen, Q., Li, C.-M., Xie, Y., Yuan, C., Lang, R., & Jiang, W.-T. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1716878 · Cited by 3
NRF1 Induces ApoEhigh Cancer-Associated Fibroblasts to Promote Stemness of Renal Cell Carcinoma
Zhang, Y., Tuo, Z., Lin, Y., Li, S. N., Jiang, Z., Jiang, C., Wang, H., Dai, F., Chen, X., Lin, G., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-0959 · Cited by 3
Self-citationLi, G., Zhang, C., Lu, T., Zhang, Z., Wu, J., Bai, R., Luo, Y., Wang, F., Song, Y., Liu, L., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-2854 · Cited by 3
SDC1 + CAFs secreting CTGF drive tumour metastasis via FGFR3 signalling in cancers
Gao, G., Ruan, Z.-H., Zhang, S.-B., He, S., Li, Y., Lyu, J., Liu, Y., Tan, X.-L., Wang, Y.-J., Liu, Z., et al. (2026) · Gut · doi:10.1136/gutjnl-2025-337606 · Cited by 3
Role of the stromal and immune microenvironment in intrahepatic cholangiocarcinoma
Affò, S., & Sia, D. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.101850 · Cited by 4
Khan, T. B., Choudhary, N., Sharma, S., Kumar, D., Kaushik, U., Gupta, V., Gowri, S., Faiyazuddin, M., & Webster, T. J. (2026) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2026.100188 · Cited by 4
ATM Deficiency Induces TGFβ-Mediated Stromal Programming in Pancreatic Cancer
Roger, É., Mummey, H. M., Zimmer, E., Srinivasan, D., Härle, A., Moubri, L., Michels, A. K., Singh, R., Ekizce, M., Melzer, M. K., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-26-0138 · Cited by 4
Zhang, S., Yuan, H., Guo, M., Zhou, Z., Hu, Y., Lv, G., Qi, H., Guo, Y., Han, J., Bronze, M. S., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-5716 · Cited by 3
Pei, S., Sjölund, J., Pan, Y., Pietras, K., & Karlsson, M. C. I. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01082-1 · Cited by 5
Wu, J., Qiao, L., Zhao, J., Wu, W., Wang, Z., Yu, G., Tian, G., Gao, Z., & Wang, Q. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s460874 · Cited by 3
Self-citationMa, J., Chen, Z., & Hou, L. (2024) · Aging · doi:10.18632/aging.206043 · Cited by 3
Mitsuhashi, A., & Nishioka, Y. (2024) · Cancer Science · doi:10.1111/cas.16385 · Cited by 3
Understanding and measuring mechanical signals in the tumor stroma
Ortiz, F. D. L. J., Cimmino, C., Ventre, M., & Cambi, A. (2024) · FEBS Open Bio · doi:10.1002/2211-5463.13923 · Cited by 5
Fu, S., Yeung, C. K., & Xu, R. (2025) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2025.102327 · Cited by 3
Kang, S. W., Helm, B. R., Wang, Y., Xiao, S., Zhang, W., Vasudev, A., Lau, K. S., Liu, Q., Richie, E. R., Hale, L. P., et al. (2025) · Development · doi:10.1242/dev.204347 · Cited by 3
Targeting B4GALT3 in BMSCs-EVs for Therapeutic Control of HCC via NF-κB pathway inhibition
Guo, J., Wang, K., Sun, Q., Liu, J., & Zheng, J. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-10013-x · Cited by 3
Su, P., Han, Y., Yi, J., Hou, Y., & Xiao, Y. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1587252 · Cited by 3
Ping, G., Tian, Y., & Zhou, Z. (2022) · Medicine · doi:10.1097/md.0000000000031382 · Cited by 3
Ma, H., Jia, J., Sun, Z., Xiao, X., Liang, S., Zhao, L., & Zhang, Z. (2024) · Diagnostic Cytopathology · doi:10.1002/dc.25276 · Cited by 3
Qiu, Z., Fan, J., He, J., Huang, X., Yang, Z., Sheng, Q., & Jin, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39732 · Cited by 3
Hu, Z., Ding, D., Song, Y., Deng, Y., Zhang, C., & Yu, T. (2024) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i2.97007 · Cited by 4
Hollar, D. (2022) · Biosystems · doi:10.1016/j.biosystems.2022.104798 · Cited by 3
Rouse, J. R., Danner, R., Wahhab, A., Pereckas, M., McClune, M. E., Steere, A. C., Strle, K., Jutras, B. L., & Lochhead, R. B. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.21.568066 · Cited by 3
Netrin G1 Ligand is a new stromal immunomodulator that promotes pancreatic cancerPreprint
Costa, D. B. V., Francescone, R., Franco‐Barraza, J., Luong, T., Graves, M., de Aquino, A. M., Steele, N. G., Gardiner, J. C., dos Santos, S. A. A., Ogier, C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.15.594354 · Cited by 3
Kowalewski, K. M., Adair, S. J., Talkington, A., Wieder, J. J., Pitarresi, J. R., Perez-Vale, K. Z., Chu, B., Dolatshahi, S., Sears, R. C., Stanger, B. Z., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.30.635486 · Cited by 3
Evoking the Cancer-immunity cycle by targeting the tumor-specific antigens in Cancer immunotherapy
Guo, X., Bai, J., Wang, X., Guo, S., Shang, Z., & Shao, Z. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114576 · Cited by 3
Cancer-associated fibroblasts as mediators of tissue microenvironment remodeling in cancer
Kugeratski, F. G., Kay, E. J., & Zanivan, S. R. (2025) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2025.102567 · Cited by 2
Metadata
- Authors
- Huang, H., Wang, Z., Zhang, Y., Pradhan, R. N., Ganguly, D., Chandra, R., Murimwa, G., Wright, S., Gu, X., Maddipati, R., Müller, S., Turley, S. J., & Brekken, R. A.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- University of California San Diego (US)
- Genentech (US)
- Corresponding author
- Huang, Huocong
- Brekken, Rolf A.
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2022-06
- Volume
- 40
- Issue
- 6
- Pages
- 656-673.e7
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC9197998
- OpenAlex
- W4229052987
- Cited by
- 542
- References
- 62
- Citations by year
- 2026: 112 · 2025: 158 · 2024: 144 · 2023: 80 · 2022: 41
- FWCI
- 44.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- SSRN Electronic Journal (acceptedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (CA210181, CA243577, CA252009)
- Burroughs Wellcome Fund
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- mesothelial cells, regulatory T cells, pancreatic cancer, tumor immune evasion, mesothelin, interleukin-1, TGF-beta, MHC class II, CD4+ T cell tolerance, lineage tracing, cancer immunotherapy
- MeSH terms
- Cancer-Associated Fibroblasts, Fibroblasts, Humans, Pancreatic Neoplasms, Transforming Growth Factor beta, T-Lymphocytes, Regulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review